AgreementEngagement Agreement |
|
|
|
You are currently viewing: This Engagement Agreement involves
WINDROSE MEDICAL PROPERTIES TRUST | Robert W. Baird & Co. Incorporated | Cohen & Steers Capital Advisors, LLC. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Engagement Agreement by:
<PAGE>
EXHIBIT 10.2
November 22, 2005
Cohen & Steers Capital Advisors, LLC
280 Park Avenue, 10th floor
New York, New York 10017
Robert W. Baird & Co. Incorporated
777 East Wisconsin Avenue
Milwaukee, WI 53202
Re: Placement of Securities of Windrose Medical Properties Trust
Dear Sirs:
This letter (the "Agreement") confirms our agreement to retain Cohen
& Steers Capital Advisors, LLC and Robert W. Baird & Co. Incorporated (the
"Co-Placement Agents") as our exclusive agents for a period commencing on the
date of this letter and terminating on December 15, 2005, unless extended by the
parties, to introduce Windrose Medical Properties Trust, a Maryland real estate
investment trust (the "Company"), to certain investors as prospective purchasers
(the "Offer") of up to 2,962,000 shares of the Company's Common Shares of
Beneficial Interest, par value $.01 per share (the "Securities") (assuming the
maximum number of Securities is issued and sold). The engagement described
herein (i) may be terminated by the Company at any time prior to the Closing (as
defined below) and (ii) shall be in accordance with applicable laws and pursuant
to the following procedures and terms and conditions:
1. The Company will:
(a) Cause the Company's independent public accountants to address to
the Company and the Co-Placement Agents and deliver to the Company and the
Co-Placement Agents (i) a letter or letters (which letters are frequently
referred to as "comfort letters") dated the date hereof, and (ii) if so
requested by the Co-Placement Agents, a "bring-down" letter delivered the date
on which the sale of Securities is consummated pursuant to the Purchase
Agreement dated the date hereof between the Company and the purchaser party
thereto (the "Purchase Agreement") (such date, the "Closing Date" and the time
of such consummation on any such Closing Date, a "Closing"), which, with respect
to the letter referred to in clause (i) above, will be substantially in the form
attached hereto as Annex I, and with respect to the letter or letters referred
to in clause (ii) above, will be in form and substance reasonably satisfactory
to the Co-Placement Agents.
(b) On the Closing Date, cause outside counsel to the Company to
deliver an opinion or opinions to the Co-Placement Agents substantially in the
form of Annex II hereto.
<PAGE>
-2-
(c) Prior to Closing apply for listing the Securities for trading on
the New York Stock Exchange, Inc. ("NYSE") and will use its commercially
reasonable efforts to obtain approval from the NYSE with respect to such listing
as soon as reasonably practicable within 10 days after the Closing Date and, if
such approval is not obtained within 10 days, to continue to use its
commercially reasonable efforts to obtain such approval as soon as practicable
thereafter.
(d) Prior to the Closing, not sell or approve the solicitation of
offers for the purchase of additional Securities in excess of the amount which
shall be authorized by the Company or in excess of the aggregate offering price
of the Securities registered pursuant to the Registration Statement (as defined
below).
(e) Use the proceeds of the offering contemplated hereby as set
forth under the caption "Use of Proceeds" in the Prospectus Supplement (as
defined below).
2. The Company authorizes the Co-Placement Agents to use the
Prospectus (as defined below) in connection with the Offer for such period of
time as the Prospectus is required by law to be delivered in connection
therewith and the Co-Placement Agents agree to do so.
3. (a) The Co-Placement Agents will use commercially reasonable
efforts on behalf of the Company in connection with the Co-Placement Agents'
services hereunder. No offers or sales of Securities shall be made to any person
without the prior approval of such person by the Company, such approval to be at
the reasonable discretion of the Company. The Co-Placement Agents' aggregate fee
for its services hereunder will be an amount equal to the sum of (i) 3.25% of
the gross proceeds received by the Company from the sale of Securities to
non-affiliates of the Co-Placement Agents as a result of the Offer and (ii) 1.0%
of the gross proceeds received by the Company from the sale of Securities to
affiliates of the Co-Placement Agents. Such fee shall be payable by the Company
at and subject to the consummation of the Closing. The Company, upon
consultation with the Co-Placement Agents, may establish in the Company's
discretion a minimum aggregate amount of Securities to be sold in the offering
contemplated hereby, which minimum aggregate amount shall be reflected in the
Prospectus. The Co-Placement Agents will not enter into any agreement or
arrangement with any broker, dealer or other person in connection with the
placement of Securities (individually, a "Participating Person" and
collectively, "Participating Persons") which will obligate the Company to pay
additional fees or expenses to or on behalf of a Participating Person without
the prior written consent of the Company, it being understood that Jefferies &
Company, Inc. will be acting as settlement agent ("Settlement Agent") in
connection with the Offer and the Company will pay the fees and expenses of the
Settlement Agent which shall be calculated at the rate of $.02 per Security
sold.
(b) The Company agrees that it will pay its own costs and expenses
incident to the performance of the obligations hereunder whether or not any
Securities are
<PAGE>
-3-
offered or sold pursuant to the Offer, including, without limitation, (i) the
filing fees and expenses, if any, incurred with respect to any filing with the
NYSE, (ii) all costs and expenses incident to the preparation, issuance,
execution and delivery of the Securities, (iii) all costs and expenses
(including filing fees) incident to the preparation, printing and filing under
the Securities Act of 1933, as amended (the "Act"), of the Registration
Statement and the Prospectus, including, without limitation, in each case, all
exhibits, amendments and supplements thereto, (iv) all costs and expenses
incurred in connection with the required registration or qualification of the
Securities issuable under the laws of such jurisdictions as the Co-Placement
Agents may reasonably designate, if any, (v) all costs and expenses incurred by
the Company in connection with the printing (including word processing and
duplication costs) and delivery of the Prospectus and Registration Statement
(including, without limitation, any preliminary and supplemental blue sky
memoranda) including, without limitation, mailing and shipping, (vi) all fees
and expenses incurred in marketing the Offer and (vii) the fees and
disbursements of Hunton & Williams, LLP, counsel to the Company, and any other
counsel to the Company, and KPMG LLP, auditors to the Company. In addition, the
Company agrees to reimburse the Co-Placement Agents for all out-of-pocket
expenses of the Co-Placement Agents in connection with the Offer, including but
not limited to the reasonable legal fees, expenses and disbursements of the
Co-Placement Agents' counsel in connection with the Offer, which out-of-pocket
expenses and fees shall not exceed $90,000.
4. (a) The Company will indemnify and hold harmless the Co-Placement
Agents and each of their partners, directors, officers, associates, affiliates,
subsidiaries, employees, consultants, attorneys and agents, and each person, if
any, controlling each of the Co-Placement Agents or any of their affiliates
within the meaning of either Section 15 of the Act or Section 20 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), from and
against any and all losses, claims, damages, liabilities or costs (and any
reasonable legal or other expenses incurred by each of the Co-Placement Agents
in investigating or defending the same or in giving testimony or furnishing
documents in response to a request of any government agency or to a subpoena) in
any way relating to, arising out of or caused by any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement or
in the Prospectus or in any way relating to, arising out of or caused by any
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. Such indemnity
agreement shall not, however, apply to any such loss, claim, damage, liability,
cost or expense (i) if such statement or omission was made in reliance upon or
in conformity with information furnished in writing to the Company by the
Co-Placement Agents or their affiliates or any of the Purchasers, Investment
Advisers or Broker-Dealers (as defined in the Purchase Agreement) or their
respective affiliates expressly for use in the Prospectus Supplement, or (ii)
which is held in a final judgment of a court of competent jurisdiction (not
subject to further appeal) to have arisen out
<PAGE>
-4-
of the gross negligence or willful misconduct of the Co-Placement Agents or
any indemnitee described in this paragraph 4(a).
(b) The Co-Placement Agents will indemnify and hold harmless the
Company and each of its trustees, officers, associates, affiliates,
subsidiaries, employees, consultants, attorneys, agents, and each person
controlling the Company or any of its affiliates within the meaning of either
Section 15 of the Act or Section 20 of the Exchange Act from and against any and
all losses, claims, damages, liabilities, costs or expenses (and any reasonable
legal or other expenses incurred by such indemnitee in investigating or
defending the same or in giving testimony or furnishing documents in response to
a request of any government agency or to a subpoena) (i) which are held in a
final judgment of a court of competent jurisdiction (not subject to further
appeal) to have arisen out of the gross negligence or willful misconduct of such
Co-Placement Agents or any of its respective partners, directors, officers,
associates, affiliates, subsidiaries, employees, consultants, attorneys and
agents, and each person, if any, controlling the Co-Placement Agents or any of
its affiliates within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act or (ii) relating to, arising out of or caused by any untrue
statement or alleged untrue statement of a material fact contained in the
Prospectus Supplement or in any way relating to, arising out of or caused by any
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, if such statement or
omission was made in reliance upon or in conformity with information furnished
in writing to the Company by the Co-Placement Agents or their affiliates or any
of the Purchasers, Investment Advisers or Broker-Dealers or their respective
affiliates expressly for use in the Prospectus Supplement, or (iii) which result
from violations by the Co-Placement Agents of law or of requirements, rules or
regulations of federal or state securities regulators, self-regulatory
associations or organizations in the securities industry, stock exchanges or
organizations with similar functions or responsibilities with respect to
securities brokers or dealers, as determined by a court of competent
jurisdiction or applicable federal or state securities regulators,
self-regulatory associations or organizations in the securities industry or
stock exchanges or organizations, as applicable.
(c) If any action, proceeding or investigation is commenced as to
which any indemnified party hereunder proposes to demand indemnification under
this letter agreement, such indemnified party will notify the indemnifying party
with reasonable promptness. The indemnifying party shall have the right to






